RxDoctor Payments Data

Gene Gordon, MD

Anesthesiology · Sylacauga, ALNPI 1073579777

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $608 and has fallen 96.6% since, to $21 in 2025. Among anesthesiology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,457in general payments, 2019–2025

Across 89 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$188
  • Almatica Pharma LLC$169
  • Collegium Pharmaceutical, Inc.$116
  • AbbVie$115
  • MDD US Operations, LLC$109
  • Biodelivery Sciences International, Inc.$102
  • plus $657 from 15 others

What the payments were for

  • Food & beverage$1,457100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,457 in reported general payments places this provider in the 90th percentile of 484 anesthesiology providers in Alabama.

See all anesthesiology providers in Alabama

Medicare billing

Part B allowed, 2024
$21,174
Medicare patients
68
Services billed
498

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen576$12,965
Buprenorphine15$6,978
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen146$4,796
Celecoxib239$3,575
Gabapentin328$3,505
Duloxetine Hcl175$2,239
Pregabalin158$1,907
Amitriptyline Hcl144$1,326
Tizanidine Hcl147$1,159
Diclofenac Sodium30$766
Tramadol Hcl102$759
Lidocaine11$755
Acetaminophen-CodeineAcetaminophen With Codeine39$686
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen38$623
Methocarbamol39$488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USABuprenorphine$12$6,97815 claims
Upsher-smith Laboratories LLCTopiramate$21$5022 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 484 anesthesiology providers in Alabama.

Other anesthesiology in Sylacauga

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →